Today we announced the successful completion of a Series D funding round, raising $130 million and bringing our total valuation to over $1B. The round was led by Premji Invest and Neuberger Berman, with participation from our existing investors. The funds will be allocated to further scale our prenatal screening and oncology diagnostics businesses, expanding the reach of our innovative tests powered by our proprietary Quantitative Counting Templates (QCTs) technology. Over 500,000 patients have benefited from our cutting-edge tests to date. We appreciate the support of our investors and the dedication of our team as we work towards our mission to make molecular diagnostics more powerful, efficient, and accessible for all. Read our press release here ➡ https://lnkd.in/gj5fF9hH Claire Rychlewski from Axios wrote about the news here ➡ https://lnkd.in/gd-FeKhh #oncology #prenatalhealth #moleculardiagnostics #BillionToOne #UNITY #Northstar #Axios
Congrats on securing the funding round!
Congrats to everyone at BillionToOne for all the science and work that went into this funding for the future. Excited to see Unity available to ever more expecting parents all over the world.
Congratulations BTO and Northstar!
Congratulations to the whole BillionToOne team!
Congrats! Well deserved..
🧬BillionToOne is transfoming prenatal screening & oncology diagnostics with innovative tests! 💰This $130Mn Series D led by Premji Invest will further advance their molecular diagnostics & allow patients to benefit from their technology. Cc. Oguzhan
Fantastic update!
Congratulations to the whole team!
Congratulations on the funding round!
Regional Sales Manager at BillionToOne
3moLet’s go!!!!!